You are here: Industry Insights > Charnwood Molecular

News List

CRO Charnwood Molecular Expands Capabilities contractpharma
July 19, 2021
$75m construction project in Loughborough creates flexible facility for the growing CRO.
UK-based CRO Charnwood Molecular reveals plans for ‘significant’ expansion in 2021 pharmatimes
April 30, 2021
UK-based contract research organisation (CRO) Charnwood Molecular has revealed its plans for expansion in 2021, which includes becoming the sole occupier of a ‘substantial’ laboratory facility in Loughborough.
Charnwood Molecular Plans Significant Expansion contractpharma
April 29, 2021
Charnwood Molecular, a UK-based preclinical discovery CRO servicing the global pharmaceutical and biopharma market, is planning a significant expansion in 2021.
Four UK CROs announce collaboration to work on potential COVID-19 therapeutics europeanpharmaceuticalreview
May 20, 2020
A group of four CROs at BioCity Nottingham have joined forces to collectively work on the research of COVID-19 therapies.